Storm Lake Capital
150 S Elizabeth Street, Rochester, MI, 48307, United States
Overview
Storm Lake Capital is a financial institution that specializes in merchant banking, investment management, and advisory services.
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Advice
- Banking
- Financial Services
- Impact Investing
- Professional Services
Investment portfolio
- SciTech Development
Led · Convertible Note · Jun 2024
SciTech Development is a clinical-stage pharmaceutical company focused on advancing next-generation cancer therapeutics via its proprietary nanotechnology drug-delivery platform. Its lead candidate, ST-001 nanoFenretinide, is in clinical trials for T-cell Non-Hodgkin Lymphoma across nine cancer centers and has produced a 100% disease control rate at the highest tested dose levels, including confirmed partial responses. Interim data suggest efficacy in both early- and late-stage patients, minimal side effects, and confirmed safety, encouraging participants to remain in the study. The company intends to extend clinical development of ST-001 into Small Cell Lung Cancer and explore additional oncology indications. Investor enthusiasm has been fueled by these results, enabling continued trial progress and pipeline expansion. SciTech has not reported commercial revenue, relying instead on successive convertible note financings to fund operations.
Team
No current team members are available.